Condition: Cutis Laxa · Sponsor: Merz North America, Inc.
The purpose of this study is to demonstrate superiority of treatment with the Ulthera System compared to untreated control for the improvement of skin laxity of the lower face, submental area and neck and to demonstrate the safety of treatment with the Ulthera System for the improvement of skin laxity of the lower face, submental area and neck.
This description comes directly from the study's public registry record.
Public Disclosure Manager Merz Aesthetics · +1 984-301-3095 · Aesthetic.Trials@merz.com
Always discuss trial participation with your own doctor first.
| Merz Investigative Site | Beijing, Beijing Municipality, China | Recruiting |
| Merz Investigative Site | Beijing, Beijing Municipality, China | Recruiting |
| Merz Investigative Site | Guangzhou, Guangdong, China | Recruiting |
| Merz Investigative Site | Nanjing, Jiangsu, China | Recruiting |
| Merz Investigative Site | Xi'an, Shaanxi, China | Recruiting |
| Merz Investigative Site | Shanghai, Shanghai Municipality, China | Recruiting |
| Merz Investigative Site | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07614997